Table of Contents
Most global Cosmetic brands entering India are familiar with CDSCO as the gatekeeper for Import registration. Far fewer understand the parallel role of the Bureau of Indian Standards (BIS) — and fewer still understand how CDSCO reviewers actively cross-reference BIS compliance during the COS 1 evaluation process.
This article explains the BIS-CDSCO interface for Cosmetics, the practical significance of the Ninth Schedule, and what your formulation, test reports, and documentation must contain to satisfy both bodies simultaneously.
The Bureau of Indian Standards is India’s national standards body, operating under the Ministry of Consumer Affairs, Food and Public Distribution. For Cosmetics, BIS publishes Indian Standards (IS) that define product quality specifications, ingredient limits, testing methods, and performance criteria across a range of Cosmetic categories.
During the COS-1 review process, CDSCO evaluates the submitted formulation and Specification sheet against the applicable BIS Ninth Schedule specifications for the product’s registered category. The most common BIS-related points of review are:
A common mistake made by applicants is submitting raw material certificates or supplier declarations instead of finished product compliance data. CDSCO reviewers often prefer evidence demonstrating that the final marketed product complies with applicable safety limits.
The BIS heavy metal limits applicable to Indian Cosmetics are:
| Heavy Metal | BIS Ninth Schedule Limit (ppm) | Notes |
| Lead | 20 ppm | |
| Arsenic | 2 ppm | As Arsenic Trioxide |
| Heavy Metal other than Lead | 100 ppm | As total of respective metals |
Table 1
BIS specifies maximum concentrations for preservatives commonly used in Cosmetics. CDSCO reviewers check whether the declared preservative concentrations in the formulation exceed BIS limits. The most queried preservatives include parabens (individual and combined limits), phenoxyethanol, MIT/CMIT (methylisothiazolinone / chloromethylisothiazolinone), and formaldehyde-releasing preservatives.
The BIS Ninth Schedule maintains a list of permitted colourants with concentration limits and restrictions on usage type (e.g., permitted only in rinse-off products, not permitted in eye-area products, not permitted in products intended for children). Every colourant declared in the formulation must appear on the permitted list. For this reason, regulatory assessment of colourants should be conducted before submission rather than after receiving a Query from CDSCO.
A practical question every global brand face is: can we submit test reports from our own laboratory or from an internationally accredited lab, or must we use an Indian NABL-accredited laboratory?
For COS-1 applications, CDSCO generally accepts test reports from laboratories accredited aligned with National Accreditation Board for Testing and Calibration Laboratories (NABL) and LAB approved from state licensing Authority.
However, if CDSCO raises a specific query about test methods and specifications parameters it may request testing or counter-testing at a NABL-accredited Indian laboratory. This is relatively uncommon for well-documented applications from reputable manufacturers but should be factored into risk planning for novel formulations or borderline ingredient levels.
An important development for global brands monitoring India’s regulatory landscape is the progressive convergence between BIS standards and CDSCO’s regulatory framework. BIS and CDSCO have been working collaboratively to align Indian cosmetic standards more closely with international frameworks — particularly the EU Cosmetics Regulation and the ISO Cosmetics standards series.
This convergence work means that EU-compliant formulations are increasingly likely to meet BIS Ninth Schedule requirements — but ‘increasingly likely’ is not the same as ‘guaranteed’. Some BIS limits remain more conservative than EU limits in specific categories. The heavy metal limits for lead in lip products, and the preservative limits for some anti-microbial actives, are areas where EU compliance alone may not satisfy Indian requirements without specific verification.
CliniExperts’ product and ingredient analysis service includes a full BIS Ninth Schedule compliance screen before every COS-2 application. We identify heavy metal, preservative, and colourant issues at the pre-filing stage — preventing the most common CDSCO deficiency queries. Contact us at contact@cliniexperts.com
CDSCO Drug Import applications are often rejected due to documentation errors, non-compliance, incorrect product classification, and delayed responses. Understanding these issues can improve approval ..
ISO 13485 is the internationally recognised standard for Quality Management Systems (QMS) in the Medical Device industry. For Indian manufacturers, it has become not just a global best-practice creden..
Learn the difference between Form 10 Drug Import License and Form 10A License, their application process, eligibility, validity, and requirements for importing Schedule X Drugs into India. Importing P..
India
Global
Sales: +91 7672005050
Reception: +91-11-45214546
9 am to 6 pm (Monday to Friday)